Welcome to our dedicated page for Deswell Inds SEC filings (Ticker: DSWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Deswell Industries Inc balances its plastic injection molding work with high-mix electronic subassemblies can be tricky—especially when those details are buried across dozens of SEC documents. Whether you’re hunting for customer concentration notes or currency risk disclosures, this page gathers every filing in one place and explains them in plain English.
Need the latest Deswell Industries quarterly earnings report 10-Q filing, a fresh 8-K material event on new tooling purchases, or live alerts on Deswell Industries insider trading Form 4 transactions? Stock Titan’s AI reads each document the moment it hits EDGAR, then surfaces what matters: plastics vs. electronics margins, cap-ex trends, and related-party dealings. With real-time updates, you’ll see Deswell Industries Form 4 insider transactions real-time alongside concise, context-rich summaries.
Not sure which form answers your question? Start here:
- 10-K annual report – full segment breakouts and risk factors, now Deswell Industries annual report 10-K simplified for quicker analysis.
- 10-Q – quarter-over-quarter revenue shifts with AI-driven commentary for instant Deswell Industries earnings report filing analysis.
- 8-K – equipment upgrades or major customer wins, with Deswell Industries 8-K material events explained.
- Form 4 – monitor Deswell Industries executive stock transactions Form 4 to spot insider sentiment.
- DEF 14A proxy – dive into Deswell Industries proxy statement executive compensation without wading through legal jargon.
From “understanding Deswell Industries SEC documents with AI” to pinpointing segment EBITDA, Stock Titan shortens the distance between raw data and informed decisions—so you can focus on timing your next move, not decoding pages of fine print.
On 28 July 2025, Passage Bio, Inc. (NASDAQ: PASG) reported that the Nasdaq Listing Qualifications staff confirmed the company has regained compliance with Nasdaq Listing Rule 5450(a)(1), which requires a minimum bid price of $1.00 per share. PASG shares closed at or above that threshold for at least 10 consecutive business days, satisfying the rule as well as all other standards for continued listing on the Nasdaq Capital Market. The compliance determination closes the deficiency matter that began with Nasdaq’s notice dated 1 August 2024, when PASG had fallen below the $1.00 level for 30 straight sessions. No additional operational or financial information was disclosed in this Form 8-K.